乳腺癌延迟DIEP皮瓣重建后复发与死亡风险
该研究在瑞典卡罗林斯卡大学医院比较1999至2013年间接受延迟DIEP皮瓣重建的乳腺癌患者与仅行乳房切除术的匹配对照,主要终点为乳腺癌特异生存。
要点
- 延迟DIEP皮瓣重建未增加乳腺癌复发风险。
- DIEP组5年乳腺癌特异生存率高于对照组。
- 调整混杂后无DIEP组总生存更低但乳腺癌特异生存无显著差异。
核心结论
- 本研究结果不支持乳腺癌患者接受DIEP皮瓣重建后复发率高于单纯乳房切除术的假设。
研究设计与样本
- 回顾性队列研究,纳入1999至2013年瑞典卡罗林斯卡大学医院250例延迟DIEP皮瓣重建患者(254次重建)与729例匹配对照。
- 对照按年龄、肿瘤及淋巴结状态、新辅助治疗和乳房切除术年份进行发病密度匹配,每例DIEP患者最多匹配4例对照。
- 主要终点为乳腺癌特异生存,采用Kaplan-Meier法和Cox比例风险回归分析。
主要发现
- 调整肿瘤及患者特征和治疗后,无DIEP重建组总生存显著更低,但乳腺癌特异生存无显著差异。
临床怎么用
- 对于适合的乳腺癌乳房切除术后患者,延迟DIEP皮瓣重建未显示增加肿瘤学复发风险。
- 临床决策时可结合本研究中DIEP组不劣于对照组的乳腺癌特异生存结果进行患者咨询。
局限性
- 原文摘要未明确报告本研究的具体局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Postmastectomy reconstruction using a deep inferior epigastric perforator (DIEP) flap is increasingly being performed in patients with breast cancer. The procedure induces extensive tissue trauma, and it has been hypothesized that the release of growth factors, angiogenic agonists and immunomodulating factors may reactivate dormant micrometastasis. The aim of the present study was to estimate the risk of breast cancer recurrence in patients undergoing DIEP flap reconstruction compared with that in patients treated with mastectomy alone. METHODS: Each patient who underwent delayed DIEP flap reconstruction at Karolinska University Hospital, Sweden, between 1999 and 2013, was compared with up to four controls with breast cancer who did not receive a DIEP flap. The control patients were selected using incidence density matching with respect to age, tumour and nodal status, neoadjuvant therapy and year of mastectomy. The primary endpoint was breast cancer-specific survival. Survival analysis was carried out using Kaplan-Meier survival estimates and Cox proportional hazard regression analysis. RESULTS: The analysis included 250 patients who had 254 DIEP flap reconstructions and 729 control patients. Median follow-up was 89 and 75 months respectively (P = 0·053). Breast cancer recurrence developed in 50 patients (19·7 per cent) in the DIEP group and 174 (23·9 per cent) in the control group (P = 0·171). The 5-year breast cancer-specific survival rate was 92·0 per cent for patients with a DIEP flap and 87·9 per cent in controls (P = 0·032). Corresponding values for 5-year overall survival were 91·6 and 84·7 per cent (P < 0·001). After adjustment for tumour and patient characteristics and treatment, patients without DIEP flap reconstruction had significantly lower overall but not breast cancer-specific survival. CONCLUSION: The present findings do not support the hypothesis that patients with breast cancer undergoing DIEP flap reconstruction have a higher rate of breast cancer recurrence than those who have mastectomy alone.
引用
- Adam H, Docherty Skogh AC, Edsander Nord Å, et al. Risk of recurrence and death in patients with breast cancer after delayed deep inferior epigastric perforator flap reconstruction. Br J Surg. 2018. PMID: 29683203. doi:10.1002/bjs.10866
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。